Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In a research letter to the British Journal of Surgery (BJS) a team of plastic surgeons reveal the effect of the COVID-19 pandemic on skin cancer surgery in the UK.

A doctor looks at the moles on someone's back

Abhilash Jain, Associate Professor of Plastic and Hand Surgery at NDORMS, was the senior author that conducted a multi-centre, prospective cohort study and survey of Plastic Surgeons. 

A national audit of skin cancer excisions by Plastic Surgeons was carried out throughout lockdown (March 16 – June 14 2020), and compared to a control - data collected immediately prior to lockdown (March 16 – 22 ) while normal NHS activities were still being undertaken. Data on 2050 patients from 32 Plastic Surgery units were included, as well as consecutive monthly surveys of Plastic Surgeons from 34 units to confirm trends. 

The study found that all skin cancer treatment was negatively affected by the pandemic:

  • The median number of general anaesthetic (GA) lists per week per institution fell from 3 pre-lockdown to 0⋅5 in April
  • Local anaesthetic (LA) lists were reduced in April and May but recovered in June.
  • The number of non-melanoma skin cancer’s (NMSC) treated per week fell by 27-47% throughout April
  • Excision of Squamous cell carcinomas (71%) was prioritised over basal cell carcinomas (28%) 

Abhilash said: “Overall we saw a lower number of surgeries for tumours taking place. At the same time there was a reduction in Moh’s surgery, radiotherapy services and fewer patients being offered immunotherapy. Long term the risk of untreated skin cancer may now be considered greater than COVID-19 and we would urge that all cancer services be resumed urgently.”

 

Similar stories

Matthew Costa elected Fellow of Academy of Medical Sciences

Matthew Costa, Professor of Orthopaedic Trauma Surgery at NDORMS, has been elected a Fellow of the Academy of Medical Sciences.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.

REF 2021 results for medical research in Oxford

Today the UK Funding Bodies have published the outcomes of the recent national research assessment exercise, the Research Excellence Framework (REF) 2021.

Nurses' Day 2022

Today marks Nurses' Day 2022. This year's theme is #BestofNursing, so we chatted to some of our amazing Research Nurses about what the Best of Nursing means to them.

Rethinking pain management after injury

NDORMS researchers are to study whether a pain management treatment using cognitive behavioural therapy will improve recovery for people who have had a major leg injury.

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.